LeonaBio (LONA) Times Interest Earned (2019 - 2026)
LeonaBio's (LONA) quarterly Times Interest Earned came in at -$4.42 in Q1 2026, up 43.12% year-on-year from -$3.09 in Q1 2025, and up 88.58% on a QoQ basis from -$38.7 in Q4 2025.
LeonaBio (LONA) Times Interest Earned (2019 - 2026) Analysis & Trends
LeonaBio (LONA) has 8 years of Times Interest Earned data on file, last reported at -$4.42 in Q1 2026.
- On a quarterly basis, Times Interest Earned rose 43.12% year-over-year to -$4.42 in Q1 2026; TTM through Mar 2026 was -$28.23, a 58.14% increase from a year earlier, with the FY2025 full-year figure at -$0.91, up 17.25% from the prior year.
- Times Interest Earned for Q1 2026 stood at -$4.42, up from -$38.7 in the prior quarter.
- Over the last five years, Times Interest Earned for LONA reached as high as -$0.17 in Q4 2024 and fell as low as -$83.15 in Q4 2022.
- Historically, Times Interest Earned has averaged -$22.99 across 5 years, with a median of -$15.32 in 2023.
- Across the five-year window, Times Interest Earned jumped 99.77% in 2024 and plunged 22761.41% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$83.15 in 2022, then grew by 9.83% to -$74.97 in 2023, then soared by 99.77% to -$0.17 in 2024, then plunged by 22761.41% to -$38.7 in 2025, then jumped by 88.58% to -$4.42 in 2026.
- Per Business Quant data, the three most recent Times Interest Earned figures were -$4.42 in Q1 2026, -$38.7 in Q4 2025, and -$7.01 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -157.58 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 7.60 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -0.38 |
| 10 | LeonaBio | 138.33 Mn | 70.65 Mn | - | -4.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.42 |
| Dec 31, 2025 | -38.70 |
| Sep 30, 2025 | -7.01 |
| Jun 30, 2025 | -6.60 |
| Mar 31, 2025 | -7.77 |
| Dec 31, 2024 | -0.17 |
| Sep 30, 2024 | -20.12 |
| Jun 30, 2024 | -42.79 |
| Mar 31, 2024 | -16.18 |
| Dec 31, 2023 | -74.97 |
| Sep 30, 2023 | -17.99 |
| Jun 30, 2023 | -15.32 |
| Mar 31, 2023 | -13.66 |
| Dec 31, 2022 | -83.15 |
| Sep 30, 2022 | -10.01 |
| Jun 30, 2022 | -29.72 |
| Mar 31, 2022 | -2.31 |
| Dec 31, 2021 | 18,778.00 |
| Sep 30, 2021 | -2.97 |
| Jun 30, 2021 | -2.16 |